Inventor
BARBOSA JOSEPH
US15 patents
⚠️ This page may combine multiple inventors who share the name “BARBOSA JOSEPH”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BRISTOL MYERS SQUIBB CO
8 patentsUS6838559B2Jan 4, 2005
Purine inhibitors of phosphodiesterase (PDE) 7
BRISTOL MYERS SQUIBB CO79 citations97
US7105667B2Sep 12, 2006
Fused heterocyclic compounds and use thereof
BRISTOL MYERS SQUIBB CO25 citations92
US7022849B2Apr 4, 2006
Quinazoline and pyrido[2,3-d]pyrimidine inhibitors of phosphodiesterase (PDE) 7
BRISTOL MYERS SQUIBB CO36 citations92
US7087614B2Aug 8, 2006
Pyrimidine inhibitors of phosphodiesterase (PDE) 7
BRISTOL MYERS SQUIBB CO35 citations89
US7601836B2Oct 13, 2009
Pyrido[2,3-D]pyrimidine inhibitors of phosphodiesterase (PDE) 7
BRISTOL MYERS SQUIBB CO11 citations83
US7595317B2Sep 29, 2009
Barbituric acid derivatives as inhibitors of TNF-α converting enzyme (TACE) and/or matrix metalloproteinases
BRISTOL MYERS SQUIBB CO7 citations73
US7981881B2Jul 19, 2011
Fused heterocyclic compounds and use thereof
BRISTOL MYERS SQUIBB CO0 citations51
US7384937B2Jun 10, 2008
Fused heterocyclic compounds and use thereof
BRISTOL MYERS SQUIBB CO0 citations51
INCYTE CORP
4 patentsUS11780840B2Oct 10, 2023
Tricyclic urea compounds as JAK2 V617F inhibitors
INCYTE CORP4 citations74
US12415809B2Sep 16, 2025
Pyrrolotriazine compounds as tam inhibitors
INCYTE CORP0 citations62
US12187725B2Jan 7, 2025
Tricyclic urea compounds as JAK2 V617F inhibitors
INCYTE CORP0 citations62
US10723705B2Jul 28, 2020
Heterocyclic compounds and uses thereof
INCYTE CORP0 citations41